Alfie
Democratizing access to precision weight loss medications
At Alfie, we've built a program based on the top research from places like Harvard and Stanford that allows us to precisely determine which weight loss medications will be most effective for our members in a multimodal approach. We're optimizing medications in complex care pathways like no one else has before. Our program has been shown to be 2x more effective than standard prescription medication and 5x more effective than habit change alone. We've raised seed capital from firms like Goodwater Capital, Nina Capital, and Pheonix Club, and various angels including the founder of OpenTrons (valued at $1.8B). Our advisors include the most cited researchers in obesity in the US.
Active Founders
Rohit Rustagi
Rohit is the COO of Alfie, and dropout from the Stanford School of Medicine. He was awarded a Fulbright Scholarship, and also holds a master's degree from Harvard. He's an avid fencer who has beat a couple of Olympians on the fencing strip too.
Alexander Singh
Alexander is a cofounder of Alfie, where he leverages experience in health-tech consulting, cloud engineering, and AI development to support men's health. He previously served as a Cloud Engineer at Deloitte where he developed vaccine management software and supported D2C health and wellness applications.
Hasan Syed
